Operaciones NuVasive - NUVA CFD
Agregar a Favoritos- Resumen
- Datos históricos
- Eventos
- Cuenta de resultados
- Balance de situación
- Flujo de caja
- Propiedad
Diferencial | 0.35 | ||||||||
Tarifa nocturna posición alcista
Long position overnight fee
Ir a la plataforma | -0.024068% | ||||||||
Tarifa nocturna posición bajista
Short position overnight fee
Ir a la plataforma | 0.001846% | ||||||||
Horario tarifa nocturna | 21:00 (UTC) | ||||||||
Cantidad comercializada mínima | 1 | ||||||||
Divisa | USD | ||||||||
Margen | 20% | ||||||||
Mercado de valores | United States of America | ||||||||
Comisión por operación | 0% |
*Information provided by Capital.com
Cierre previo* | 51.96 |
Abrir* | 51.73 |
Cambio de 1 año* | -1.52% |
Rango del día* | 51.73 - 52.64 |
Rango de 52 semanas | 35.17-60.47 |
Volumen medio (10 días) | 982.19K |
Volumen medio (3 meses) | 20.59M |
Capitalización de mercado | 1.92B |
Ratio P/E | 62.79 |
Acciones en circulación | 52.19M |
Ingresos | 1.20B |
EPS | 0.59 |
Dividendo (Rendimiento %) | N/A |
Beta | 1.09 |
Próxima fecha de resultados | May 2, 2023 |
"Todos los datos son proporcionados por Refinitiv, excepto los datos marcados con un asterisco, que son *datos proporcionados por Capital.com"
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Cierre | Change | Change (%) | Apertura | High | Low |
---|---|---|---|---|---|---|
Dec 31, 2021 | 52.32 | 1.50 | 2.95% | 50.82 | 52.75 | 50.61 |
Dec 30, 2021 | 51.96 | 1.08 | 2.12% | 50.88 | 53.44 | 50.52 |
Dec 29, 2021 | 52.47 | 1.46 | 2.86% | 51.01 | 53.15 | 51.01 |
Dec 28, 2021 | 51.76 | 0.33 | 0.64% | 51.43 | 53.17 | 50.66 |
Dec 27, 2021 | 52.55 | 1.24 | 2.42% | 51.31 | 52.70 | 51.30 |
Dec 23, 2021 | 52.18 | 1.43 | 2.82% | 50.75 | 52.81 | 50.02 |
Oct 11, 2018 | 66.74 | 0.00 | 0.00% | 66.74 | 66.74 | 66.74 |
NuVasive Events
Hora (UTC) (UTC) | País | Evento |
---|---|---|
No events scheduled |
- Anual
- Trimestral
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Ingresos totales | 962.132 | 1026.69 | 1101.71 | 1168.07 | 1050.58 | 1138.99 |
Ingresos | 962.132 | 1026.69 | 1101.71 | 1168.07 | 1050.58 | 1138.99 |
Coste de los ingresos, total | 240.105 | 268.441 | 311.159 | 312.357 | 321.631 | 322.278 |
Beneficio bruto | 722.027 | 758.244 | 790.555 | 855.713 | 728.951 | 816.71 |
Gastos totales de explotación | 838.533 | 915.199 | 1047.55 | 1045.02 | 1012.28 | 1151.02 |
Gastos de venta/general/administración Gastos, total | 533.6 | 539.507 | 575.836 | 611.181 | 547.195 | 610.085 |
Investigación y desarrollo | 47.999 | 50.425 | 61.695 | 72.38 | 79.838 | 92.626 |
Depreciation / Amortization | 42.001 | 48.039 | 50.67 | 51.097 | 51.726 | 57.309 |
Gastos (ingresos) extraordinarios | -25.172 | 8.787 | 48.186 | -1.995 | 11.889 | 68.719 |
Ingresos de explotación | 123.599 | 111.486 | 54.168 | 123.05 | 38.303 | -12.029 |
Ingresos por intereses (gastos), netos No operativos | -58.514 | -37.581 | -37.271 | -36.608 | -68.994 | -20.896 |
Otros, netos | -0.305 | -1.542 | -8.174 | -5.925 | -16.854 | -25.459 |
Ingresos netos antes de impuestos | 64.78 | 72.363 | 8.723 | 80.517 | -47.545 | -58.384 |
Ingresos netos después de impuestos | 35.471 | 60.315 | 12.479 | 65.234 | -37.153 | -64.086 |
Intereses menores | 1.721 | 1.743 | 0 | 0 | ||
Beneficio neto antes de partidas extra. Elementos | 37.192 | 62.058 | 12.479 | 65.234 | -37.153 | -64.086 |
Total de partidas extraordinarias | 0 | 19.54 | 0 | |||
Ingresos netos | 37.192 | 81.598 | 12.479 | 65.234 | -37.153 | -64.086 |
Ingresos disponibles para los accionistas, excluyendo las partidas extra. Elementos | 37.192 | 62.058 | 12.479 | 65.234 | -37.153 | -64.086 |
Ingresos disponibles para los accionistas, incluidos los elementos extra. Elementos | 37.192 | 81.598 | 12.479 | 65.234 | -37.153 | -64.086 |
Ajuste por dilución | 0.13838 | |||||
Beneficio neto diluido | 37.3304 | 81.598 | 12.479 | 65.234 | -37.153 | -64.086 |
Promedio ponderado de acciones diluidas | 54.102 | 55.193 | 52.355 | 53.16 | 51.416 | 51.589 |
BPA diluido sin partidas extraordinarias | 0.69 | 1.12438 | 0.23835 | 1.22713 | -0.7226 | -1.24224 |
Dividends per Share - Common Stock Primary Issue | 0 | |||||
BPA normalizado diluido | 0.43524 | 1.25708 | 0.89618 | 1.19672 | -0.56541 | -0.37641 |
Q1 2021 | Q2 2021 | Q3 2021 | Q4 2021 | Q1 2022 | |
---|---|---|---|---|---|
Ingresos totales | 271.249 | 294.828 | 270.836 | 302.075 | 290.762 |
Ingresos | 271.249 | 294.828 | 270.836 | 302.075 | 290.762 |
Coste de los ingresos, total | 71.811 | 78.28 | 88.652 | 83.535 | 79.097 |
Beneficio bruto | 199.438 | 216.548 | 182.184 | 218.54 | 211.665 |
Gastos totales de explotación | 258.91 | 284.082 | 277.469 | 330.556 | 278.828 |
Gastos de venta/general/administración Gastos, total | 145.954 | 157.397 | 146.056 | 160.678 | 160.281 |
Investigación y desarrollo | 22.224 | 21.764 | 23.405 | 25.233 | 23.358 |
Depreciation / Amortization | 13.337 | 15.088 | 14.805 | 14.079 | 13.032 |
Gastos (ingresos) extraordinarios | 5.584 | 11.553 | 4.551 | 47.031 | 3.06 |
Ingresos de explotación | 12.339 | 10.746 | -6.633 | -28.481 | 11.934 |
Ingresos por intereses (gastos), netos No operativos | -7.943 | -4.379 | -4.297 | -4.277 | -4.336 |
Otros, netos | -12.526 | 1.269 | -13.082 | -1.12 | 16.244 |
Ingresos netos antes de impuestos | -8.13 | 7.636 | -24.012 | -33.878 | 23.842 |
Ingresos netos después de impuestos | -7.51 | 1.799 | -21.639 | -36.736 | 19.201 |
Beneficio neto antes de partidas extra. Elementos | -7.51 | 1.799 | -21.639 | -36.736 | 19.201 |
Ingresos netos | -7.51 | 1.799 | -21.639 | -36.736 | 19.201 |
Ingresos disponibles para los accionistas, excluyendo las partidas extra. Elementos | -7.51 | 1.799 | -21.639 | -36.736 | 19.201 |
Ingresos disponibles para los accionistas, incluidos los elementos extra. Elementos | -7.51 | 1.799 | -21.639 | -36.736 | 19.201 |
Beneficio neto diluido | -7.51 | 1.799 | -21.639 | -36.736 | 19.201 |
Promedio ponderado de acciones diluidas | 51.379 | 52.211 | 51.669 | 51.739 | 62.579 |
BPA diluido sin partidas extraordinarias | -0.14617 | 0.03446 | -0.4188 | -0.71003 | 0.30683 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
BPA normalizado diluido | -0.07553 | 0.17829 | -0.36155 | -0.11917 | 0.34621 |
- Anual
- Trimestral
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Total Activo Corriente | 575.443 | 560.063 | 618.209 | 764.336 | 1562.18 | 802.424 |
Efectivo e inversiones a corto plazo | 153.643 | 72.803 | 117.84 | 213.034 | 1030.01 | 246.091 |
Efectivo y Equivalentes | 153.643 | 72.803 | 117.84 | 213.034 | 856.869 | 246.091 |
Inversiones a corto plazo | 0 | 173.145 | 0 | |||
Total deudores, neto | 171.595 | 200.22 | 196.487 | 211.532 | 207.071 | 214.398 |
Accounts Receivable - Trade, Net | 171.595 | 200.22 | 196.487 | 211.532 | 207.071 | 214.398 |
Total Inventory | 208.249 | 247.138 | 273.244 | 312.419 | 300.623 | 315.845 |
Prepaid Expenses | 41.956 | 36.001 | 30.638 | 27.351 | 24.476 | 26.09 |
Total Assets | 1570.8 | 1640.14 | 1707.86 | 1885.29 | 2693.08 | 2154.07 |
Property/Plant/Equipment, Total - Net | 181.524 | 215.326 | 238.841 | 333.25 | 388.639 | 406.651 |
Property/Plant/Equipment, Total - Gross | 404.689 | 576.382 | 726.529 | 841.718 | 909.166 | |
Accumulated Depreciation, Total | -223.165 | -337.541 | -393.279 | -453.079 | -502.515 | |
Goodwill, Net | 485.685 | 536.926 | 561.366 | 561.064 | 559.553 | 633.467 |
Intangibles, Net | 291.143 | 280.774 | 252.048 | 201.092 | 152.264 | 242.675 |
Long Term Investments | 0 | |||||
Other Long Term Assets, Total | 37.009 | 47.051 | 37.395 | 25.548 | 30.442 | 68.858 |
Total Current Liabilities | 242.497 | 161.395 | 179.46 | 206.917 | 836.362 | 200.891 |
Accounts Payable | 9.121 | 8.799 | 11.827 | 17.386 | 16.192 | |
Accrued Expenses | 93.355 | 55.618 | 130.346 | 155.188 | 135.748 | 146.454 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 61.701 | 645.303 | 0 | |||
Other Current Liabilities, Total | 78.32 | 30.01 | 40.315 | 39.902 | 37.925 | 38.245 |
Total Liabilities | 875.868 | 844.569 | 873.334 | 970.083 | 1774.16 | 1358.87 |
Total Long Term Debt | 564.412 | 582.92 | 602.526 | 624.203 | 772.735 | 885.869 |
Long Term Debt | 564.412 | 582.92 | 602.526 | 623.298 | 770.923 | 884.984 |
Deferred Income Tax | 18.607 | 18.87 | 4.964 | 14.655 | 2.807 | 3.049 |
Minority Interest | 5.588 | 3.845 | 0 | |||
Other Liabilities, Total | 44.764 | 77.539 | 86.384 | 124.308 | 162.26 | 269.059 |
Total Equity | 694.936 | 795.571 | 834.525 | 915.207 | 918.918 | 795.207 |
Common Stock | 0.055 | 0.06 | 0.061 | 0.062 | 0.062 | 0.063 |
Additional Paid-In Capital | 1010.24 | 1363.55 | 1397.83 | 1429.85 | 1550 | 1434.98 |
Retained Earnings (Accumulated Deficit) | -66.859 | 4.762 | 17.241 | 82.475 | 45.322 | 45.708 |
Treasury Stock - Common | -237.867 | -565.867 | -571.978 | -587.766 | -668.882 | -677.748 |
Other Equity, Total | -10.631 | -6.933 | -8.628 | -9.418 | -7.585 | -7.792 |
Total Liabilities & Shareholders’ Equity | 1570.8 | 1640.14 | 1707.86 | 1885.29 | 2693.08 | 2154.07 |
Total Common Shares Outstanding | 50.4258 | 51.1622 | 51.5316 | 52.1451 | 51.376 | 51.769 |
Other Current Assets, Total | 3.901 | |||||
Payable/Accrued | 75.767 | |||||
Capital Lease Obligations | 0.905 | 1.812 | 0.885 |
Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
---|---|---|---|---|---|
Total Activo Corriente | 781.56 | 765.748 | 770.361 | 802.424 | 792.214 |
Efectivo e inversiones a corto plazo | 233.857 | 204.138 | 234.578 | 246.091 | 205.312 |
Efectivo y Equivalentes | 233.857 | 204.138 | 234.578 | 246.091 | 205.312 |
Inversiones a corto plazo | 0 | 0 | 0 | 0 | |
Total deudores, neto | 205.026 | 216.915 | 199.366 | 214.398 | 231.425 |
Accounts Receivable - Trade, Net | 205.026 | 216.915 | 199.366 | 214.398 | 231.425 |
Total Inventory | 315.749 | 319.734 | 311.414 | 315.845 | 324.403 |
Prepaid Expenses | 26.928 | 24.961 | 25.003 | 26.09 | 31.074 |
Total Assets | 2164.78 | 2146.47 | 2134.03 | 2154.07 | 2160.5 |
Property/Plant/Equipment, Total - Net | 388.136 | 401.762 | 406.785 | 406.651 | 414.345 |
Goodwill, Net | 636.422 | 636.727 | 633.121 | 633.467 | 636.703 |
Intangibles, Net | 296.514 | 278.097 | 256.416 | 242.675 | 233.301 |
Other Long Term Assets, Total | 62.153 | 64.139 | 67.35 | 68.858 | 83.938 |
Total Current Liabilities | 224.876 | 193.732 | 195.362 | 200.891 | 248.729 |
Payable/Accrued | 106.576 | 110.702 | 110.796 | 115.614 | 115.674 |
Accrued Expenses | 66.908 | 74.306 | 75.368 | 76.463 | 65.891 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 0 | 0 | 0 | 0 | |
Other Current Liabilities, Total | 51.392 | 8.724 | 9.198 | 8.814 | 67.164 |
Total Liabilities | 1329.4 | 1305.57 | 1309.84 | 1358.87 | 1348.58 |
Total Long Term Debt | 880.939 | 882.498 | 884.167 | 885.869 | 887.593 |
Long Term Debt | 879.473 | 881.381 | 883.18 | 884.984 | 886.793 |
Capital Lease Obligations | 1.466 | 1.117 | 0.987 | 0.885 | 0.8 |
Deferred Income Tax | 3.042 | 2.798 | 2.683 | 3.049 | 12.807 |
Other Liabilities, Total | 220.541 | 226.544 | 227.625 | 269.059 | 199.451 |
Total Equity | 835.387 | 840.901 | 824.196 | 795.207 | 811.921 |
Common Stock | 0.062 | 0.062 | 0.063 | 0.063 | 0.063 |
Additional Paid-In Capital | 1411.17 | 1420.28 | 1425.24 | 1434.98 | 1441.78 |
Retained Earnings (Accumulated Deficit) | 102.284 | 104.083 | 82.444 | 45.708 | 64.909 |
Treasury Stock - Common | -668.99 | -675.899 | -676.244 | -677.748 | -683.093 |
Other Equity, Total | -9.139 | -7.622 | -7.309 | -7.792 | -11.741 |
Total Liabilities & Shareholders’ Equity | 2164.78 | 2146.47 | 2134.03 | 2154.07 | 2160.5 |
Total Common Shares Outstanding | 51.379 | 51.665 | 51.677 | 51.769 | 51.949 |
Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 |
- Anual
- Trimestral
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Ingresos netos/Línea de salida | 35.471 | 79.855 | 12.479 | 65.234 | -37.153 | -64.086 |
Efectivo de actividades de explotación | 158.085 | 176.969 | 219.183 | 235.29 | 185.911 | 182.174 |
Efectivo de actividades de explotación | 102.713 | 121.176 | 129.765 | 135.593 | 140.937 | 149.524 |
Deferred Taxes | 26.292 | -12.838 | -11.396 | 5.844 | -18.007 | -4.141 |
Partidas no monetarias | 97.11 | 65.112 | 97.667 | 80.384 | 151.489 | 150.176 |
Cash Taxes Paid | -20.499 | 1.459 | 5.51 | 5.828 | 1.873 | 11.879 |
Intereses pagados en efectivo | 13.249 | 15.897 | 17.182 | 16.145 | 19.914 | 16.294 |
Cambios en el capital circulante | -103.501 | -76.336 | -9.332 | -51.765 | -51.355 | -49.299 |
Efectivo de actividades de inversión | -304.885 | -174.861 | -161.285 | -134.484 | -281.934 | -136.065 |
Gastos de capital | -94.29 | -112.491 | -109.603 | -130.384 | -109.589 | -112.456 |
Otras partidas de flujo de caja de inversión, total | -210.595 | -62.37 | -51.682 | -4.1 | -172.345 | -23.609 |
Efectivo procedente de actividades de financiación | 110.823 | -87.028 | -14.578 | -6.644 | 736.656 | -653.349 |
Elementos de flujo de caja de financiación | -2.256 | -21.842 | -19.777 | 1.419 | -8.787 | -1.328 |
Emisión (retiro) de acciones, neto | 29.608 | -1.869 | 5.199 | -8.063 | 19.42 | -2.595 |
Emisión (amortización) de deuda, neta | 83.471 | -63.317 | 0 | 0 | 726.023 | -649.426 |
Efectos del cambio de divisas | -0.929 | 2.07 | -1.283 | 0.131 | 3.202 | -3.538 |
Variación neta de la tesorería | -36.906 | -82.85 | 42.037 | 94.293 | 643.835 | -610.778 |
Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -7.51 | -5.711 | -27.35 | -64.086 | 19.201 |
Cash From Operating Activities | 31.639 | 79.396 | 144.77 | 182.174 | 6.539 |
Cash From Operating Activities | 36.432 | 73.954 | 111.818 | 149.524 | 36.801 |
Deferred Taxes | -3.535 | -2.942 | -5.211 | -4.141 | -3.891 |
Non-Cash Items | 33.315 | 50.951 | 89.929 | 150.176 | -7.717 |
Changes in Working Capital | -27.063 | -36.856 | -24.416 | -49.299 | -37.855 |
Cash From Investing Activities | -2.655 | -77.293 | -110.439 | -136.065 | -34.17 |
Capital Expenditures | -26.27 | -54.683 | -86.83 | -112.456 | -33.223 |
Other Investing Cash Flow Items, Total | 23.615 | -22.61 | -23.609 | -23.609 | -0.947 |
Cash From Financing Activities | -649.825 | -653.261 | -653.973 | -653.349 | -12.705 |
Financing Cash Flow Items | -0.344 | -0.674 | -1.041 | -1.328 | -7.36 |
Issuance (Retirement) of Stock, Net | -0.055 | -3.161 | -3.506 | -2.595 | -5.345 |
Issuance (Retirement) of Debt, Net | -649.426 | -649.426 | -649.426 | -649.426 | 0 |
Foreign Exchange Effects | -2.171 | -1.573 | -2.649 | -3.538 | -0.443 |
Net Change in Cash | -623.012 | -652.731 | -622.291 | -610.778 | -40.779 |
Nombre del Inversor | Tipo de inversor | Porcentaje pendiente | Acciones en propiedad | Cambio de acciones | Fechas de holding | Índice de rotación |
---|---|---|---|---|---|---|
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 16.0321 | 8367512 | 2689624 | 2022-12-31 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 11.9284 | 6225673 | 822094 | 2022-12-31 | LOW |
Thrivent Asset Management, LLC | Investment Advisor | 6.1686 | 3219514 | 647625 | 2022-12-31 | LOW |
Macquarie Investment Management | Investment Advisor | 4.4331 | 2313720 | -15467 | 2022-12-31 | LOW |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 4.0595 | 2118756 | 285974 | 2022-12-31 | LOW |
Dimensional Fund Advisors, L.P. | Investment Advisor/Hedge Fund | 2.7738 | 1447731 | 106621 | 2022-12-31 | LOW |
Paradice Investment Management LLC | Investment Advisor | 2.6646 | 1390688 | 195605 | 2022-12-31 | LOW |
JP Morgan Asset Management | Investment Advisor | 2.4859 | 1297438 | -250697 | 2022-12-31 | LOW |
Channing Capital Management, LLC | Investment Advisor | 2.2594 | 1179211 | -71535 | 2022-12-31 | MED |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.851 | 966072 | 19879 | 2022-12-31 | LOW |
Magnetar Capital Partners LP | Investment Advisor/Hedge Fund | 1.6194 | 845201 | -46632 | 2022-12-31 | HIGH |
Arrowstreet Capital, Limited Partnership | Investment Advisor/Hedge Fund | 1.5754 | 822225 | 402045 | 2022-12-31 | MED |
Point72 Asset Management, L.P. | Hedge Fund | 1.5686 | 818700 | 818700 | 2022-12-31 | HIGH |
Stephens Investment Management Group, LLC | Investment Advisor | 1.5338 | 800504 | 2138 | 2022-12-31 | LOW |
Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 1.5284 | 797685 | 282862 | 2022-12-31 | LOW |
Loomis, Sayles & Company, L.P. | Investment Advisor/Hedge Fund | 1.5109 | 788586 | -18861 | 2022-12-31 | LOW |
Frontier Capital Management Company, LLC | Investment Advisor | 1.4967 | 781140 | 12586 | 2022-12-31 | LOW |
Capital World Investors | Investment Advisor | 1.4677 | 766000 | 0 | 2022-12-31 | LOW |
Victory Capital Management Inc. | Investment Advisor/Hedge Fund | 1.3961 | 728657 | 90777 | 2022-12-31 | LOW |
Fisher Investments | Investment Advisor/Hedge Fund | 1.3731 | 716632 | -1699 | 2022-12-31 | LOW |
¿Por qué operar con Capital.com? Nuestros números hablan por nosotros
Capital.com GroupTraders
Clientes activos mensualmente
Volumen mensual de inversión
Retiros por mes
Calculadora de trading
Calcula tus P&L hipotéticas en el supuesto de haber abierto una operación con CFD en una fecha determinada (selecciona una fecha) y haberla cerrado en otra fecha (selecciona una fecha).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
NuVasive Company profile
Sobre NuVasive, Inc.
NUVASIVE, INC. es una compañía de dispositivos médicos. La Compañía se enfoca en desarrollar productos quirúrgicos mínimamente disruptivos y soluciones integradas en el procedimiento para la cirugía de la columna vertebral. Su cartera de productos se centra en aplicaciones para la cirugía de fusión de la columna vertebral, incluidos los productos biológicos utilizados para ayudar en el proceso de fusión espinal. Su principal oferta de productos incluye una plataforma quirúrgica mínimamente disruptiva llamada Maximum Access Surgery (MAS). La plataforma incluye sus sistemas de prevención y detección de nervios impulsados por software, incluido NVM5, y servicios y soporte de monitoreo intraoperativo; MaXcess, un sistema de retractor dividido integrado y una gama de implantes y productos biológicos. La plataforma combina tres categorías de productos: retractores MaXcess, implantes especializados y productos de fijación, y sistemas de monitoreo nervioso y ofertas de servicios que permiten a los cirujanos detectar y navegar alrededor de los nervios, al tiempo que dirigen el acceso personalizado a la espina dorsal para la entrega de implantes.
- IndustriaMedical Equipment / Supplies / Distribution
- Dirección7475 Lusk Blvd, SAN DIEGO, CA, United States (USA)
- Empleados2900
- CEOJ. Christopher Barry
Industry: | Medical Equipment, Supplies & Distribution (NEC) |
7475 Lusk Blvd
SAN DIEGO
CALIFORNIA 92121
US
Cuenta de resultados
- Annual
- Quarterly
A la gente también le interesa
¿Aún estás buscando un bróker de confianza?
Únete a más de 500.000 traders de todo el mundo que eligen operar con Capital.com